The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China

Background: Due to the absence of specific symptoms and low survival rate, efficient biomarkers for hepatocellular carcinoma (HCC) diagnosis are urgently required. The purpose of this study was to evaluate the diagnostic performance of protein induced by vitamin K absence or antagonist-II (PIVKA-II)...

Full description

Bibliographic Details
Main Authors:	Gao, C. (Author), Guo, Q. (Author), Ji, J. (Author), Jia, Y. (Author), Jiang, F. (Author), Li, S. (Author), Liu, L. (Author), Liu, N. (Author), Lou, J. (Author), Wang, Y. (Author), Wen, X. (Author), Zhang, Y. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	adult Adult aged Aged Aged, 80 and over Article biological marker Biomarkers blood cancer patient cancer risk Carcinoma, Hepatocellular China chronic liver disease chronic liver diseases clinical evaluation clinical trial cohort analysis Cross-Sectional Studies cross-sectional study decarboxyprothrombin diagnostic evaluation female Female hepatocellular carcinoma human Humans immunoassay Immunoassay liver cell carcinoma liver cirrhosis liver disease Liver Diseases Liver Neoplasms liver tumor major clinical study male Male middle aged Middle Aged multicenter study multi-center study Protein induced by vitamin K absence or antagonist-II protein precursor Protein Precursors prothrombin Prothrombin sensitivity and specificity Sensitivity and Specificity very elderly
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China

Internet

Similar Items